Eiko Lifesciences standalone net profit rises 337.50% in the June 2024 quarter
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 65.13% to Rs 10.75 crore in the quarter ended June 2024 as against Rs 6.51 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 10.75 | 6.51 | 65 |
OPM % | 3.81 | 4.15 | - |
PBDT | 0.64 | 0.27 | 137 |
PBT | 0.47 | 0.11 | 327 |
NP | 0.35 | 0.08 | 338 |

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

10 Financial Planning Checklist For 2025
7 mins read . Aug 12, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •